Recall of digoxin tablets following reports of toxicity
All strengths of Digitek digoxin tablets are recalled by Actavis Totowa.
Actavis Totowa LLC has issued a Class I nationwide recall of all strengths of its digoxin tablets (Digitek) after discovering that some of the tablets may contain twice the appropriate amount of active ingredient. The affected tablets are also twice the thickness of a normal tablet. According the the manufacturer, the tablets are distributed by Mylan Pharmaceuticals, under a “Bertek” label, and by UDL Laboratories, under a “UDL” label. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, bradycardia, cardiac instability, and even death. Customer inquiries related to the recall should be directed to Stericycle customer service at 1-(888)-276-6166. Additional information about the recall can be found online.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
